This course will address the rapidly changing landscape in the management and treatment of non-Hodgkin lymphoma, Hodgkin Lymphoma, and chronic lymphocytic leukemia. Through presentations by expert thought leaders reviewing the most current data and three panel discussions divided into aggressive lymphomas, indolent lymphomas, and Hodgkin Lymphoma/chronic lymphocytic leukemia, participants will have the opportunity to discuss optimal management and to learn the most critical updates in these diseases.